The Pharma Data

AUGUST 19, 2021

Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company’s commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. today announced U.S.

FDA Approval 52

FDA Approval DNA Reagent Protein 52

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

XTalks

OCTOBER 7, 2020

LabCorp was given the green light for the test by the FDA last week, which is set to be rolled out soon. Related: Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test. The novel method significantly increases testing efficiency while decreasing the need for testing reagents and supplies.

Reagent 98

Reagent RNA Life Science FDA Approval 98

Pharmaceutical Technology

APRIL 28, 2023

Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026.

Manufacturing 130

Manufacturing Antibody Clinical Supply Protein 130

The Pharma Data

JANUARY 27, 2021

Avacta has worked with Adeptrix Inc (Beverly, MA, USA) to develop a coronavirus antigen test that combines enrichment of the sample using Affimer® reagents with the analytical power of mass-spectrometry. 28, 2021 09:19 UTC. CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.–(

Reagent 52

Reagent In-Vitro FDA Approval Development 52

Drug Discovery World

DECEMBER 13, 2023

Moreover, custom antibodies are a key reagent in companion diagnostics for these novel therapeutics. Caplacizumab, for the treatment of a rare blood clotting disease, achieved FDA approval in 2019 2. When working with a novel therapeutic, the tools you need to monitor its activity likely do not exist off the shelf.

Life Science 59

Life Science Antibody Manufacturing In-Vivo 59

Drug Discovery World

JUNE 14, 2023

BCA also provides laeukopaks for use in research and development, as well as cell-based reagents used in biotherapies manufacturing.” BCA member testing laboratories have specialised diagnostic labs and have the regulatory processes in place to support clinical trials. Without it, this work stops.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52